ZVRA

Zevra Therapeutics, Inc.

4.77 USD
+0.04 (+0.85%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Zevra Therapeutics, Inc. stock is up 5.53% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 9 May’s closed higher than April. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Mar 13:55 16 Aug, 2024 2.50 CALL 100 400
06 May 13:42 16 Aug, 2024 5.00 CALL 335 883

About Zevra Therapeutics, Inc.

KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. Its product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, stimulant use disorder, and CNS rare diseases, including idiopathic hypersomnia (IH)